Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the antibody discovery market?

The scale of the antibody discovery market has significantly expanded in recent times. The market is projected to increase from $8.96 billion in 2024 to $9.87 billion in 2025, reflecting an impressive compound annual growth rate (CAGR) of 10.2%. The surge in the historical period is linked to an escalation in investment within drug discovery and an enhancement in research and development activities, along with the existence of numerous healthcare research centers and academic institutions.

What will be the antibody discovery market size in the future?

In the coming years, the antibody discovery market is predicted to experience significant expansion. It is projected to rise to $14.6 billion in 2029, with a compound annual growth rate (CAGR) of 10.3%. The surge during the projected period is due to a heightened need for antibody drug discovery services and platforms, a sharp increase in resources for developing new technologies, and a growing demand for precision therapeutics. Additionally, the use of antibodies has extended beyond their traditional therapeutic roles. The forecast period showcases trends such as elevated research and development undertakings, a heightened demand for monoclonal antibodies, an increased embracement of new technologies, a growing requirement for targeted therapeutics, and the creation of innovative antibody formats.

Get your antibody discovery market report here!

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

What main drivers are fueling expansion in the antibody discovery market?

The expansion of the antibody discovery market is anticipated to be driven by the increasing demand for precision therapeutics. Precision therapeutics, otherwise known as personalized therapeutics, involves tailoring medical treatment strategies and interventions to the unique attributes of each patient. Antibody discovery plays a crucial part in precision therapeutics by facilitating the creation of targeted therapies like monoclonal antibodies. These are designed to interact specifically and accurately with disease-related molecules or cells for more effective and personalized care. For instance, the US-based Personalized Medicine Coalition reported in January 2023 that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Of these 35 therapeutic NMEs, around 34% or 12 of them were classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the increasing demand for precision therapeutics will boost the antibody discovery market’s growth.

What key areas define the segmentation of the global antibody discovery market?

The antibody discovery market covered in this report is segmented –

1) By Methods: Phage Display, Hybridoma, Other Methods

2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:

1) By Phage Display: Selection And Screening Techniques, Optimization Methods

2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

Who are the dominant players expanding their reach in the antibody discovery market?

Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

How are evolving market trends shaping antibody discovery Strategies?

Leading firms present in the antibody discovery market are leveraging cutting-edge innovation, such as an artificial intelligence (AI) infused computational antibody drug discovery platform, to enhance the precision and speed of antibody creation. This revolutionary AI-based computational antibody drug discovery platform employs AI alongside computational strategies to hasten the detection and optimization of therapeutic antibodies. For example, in October 2023, Belgium’s SwiftPharma BV, which specializes in creating recombinant proteins using a plant-based system, unveiled an AI-powered antibody discovery platform. This bleeding-edge solution amalgamates AI, big data, machine learning, and phage display methods to instantly forecast antibody-antigen binding with high specificity and affinity. Through adopting an approach similar to natural language processing, this platform generates a broad array of antibody variants, facilitating SwiftPharma in effectively creating ample antibody libraries. This evolved system propels the discovery of promising antibody drugs at an unparalleled pace.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13783

Which regions are emerging as leaders in the antibody discovery market?

North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Antibiotics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Antibiotic Free Meat Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report

Inhaled Antibiotics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: